Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

HIV Infection

Free Subscription Articles published in JAMA Retrieve available abstracts of 69 articles: HTML format

Single Articles

May 2024
1. MCKENNA M
   Produce Prescriptions Sound Good, but Data to Support Them Are Lacking-That Could Soon Change.
   JAMA. 2024;331:1433-1436.
   PubMed    
   
   
   April 2024
2. HARRIS E
   WHO Documents Rising Resistance to First-Line HIV Drug.
   JAMA. 2024 Apr 5. doi: 10.1001/jama.2024.4497.
   PubMed    
   
   
   March 2024
3. STOOPLER ET, Villa A, Bindakhil M, Diaz DLO, et al
   Common Oral Conditions: A Review.
   JAMA. 2024;331:1045-1054.
   PubMed     Abstract available
   
   
   
4. SHETH AN, Momplaisir F, Dumond JB
   Shifting the Narrative of Preexposure Prophylaxis Adherence Counseling for Cisgender Women.
   JAMA. 2024;331:912-914.
   PubMed    
   
   
   
5. PECK RN, Issarow B, Kisigo GA, Kabakama S, et al
   Linkage Case Management and Posthospitalization Outcomes in People With HIV: The Daraja Randomized Clinical Trial.
   JAMA. 2024 Mar 6:e242177. doi: 10.1001/jama.2024.2177.
   PubMed     Abstract available
   
   
   
6. AMICO KR
   A Linkage-to-Care Intervention for Hospitalized People With HIV: High Value at Minimal Cost.
   JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.0271.
   PubMed    
   
   
   
7. HARRIS E
   Long-Acting HIV Treatment Superior to Daily Oral Drugs.
   JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1570.
   PubMed    
   
   
   
8. MARRAZZO J, Tao L, Becker M, Leech AA, et al
   HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women.
   JAMA. 2024 Mar 1. doi: 10.1001/jama.2024.0464.
   PubMed     Abstract available
   
   
   
9. SAX PE, Thompson MA, Saag MS
   Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel.
   JAMA. 2024 Mar 1. doi: 10.1001/jama.2024.2985.
   PubMed    
   
   
   February 2024
10. HARRIS E
    Antibiotic Use After Sex Might Not Prevent STIs Among Women.
    JAMA. 2024;331:384-385.
    PubMed    
    
    
    January 2024
11. HARRIS E
    Higher Out-of-Pocket Costs Might Lead People to Forgo HIV Prevention.
    JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28342.
    PubMed    
    
    
    
12. KAPOOR N, Dietz C, Buettner BP
    An Incarcerated Individual With Weight Loss and Interstitial Pulmonary Infiltrates.
    JAMA. 2024 Jan 8. doi: 10.1001/jama.2023.24260.
    PubMed    
    
    
    December 2023
13. OKA H, Sumitomo S, Ohmura K
    A 52-Year-Old With Painful Fingertips.
    JAMA. 2023 Dec 4. doi: 10.1001/jama.2023.22011.
    PubMed    
    
    
    
14. ROSE MR, Chida NM, Jones JL
    Fourth-Generation HIV Testing.
    JAMA. 2023 Dec 1. doi: 10.1001/jama.2023.18137.
    PubMed    
    
    
    
15. MALEBRANCHE D
    Pride.
    JAMA. 2023 Dec 1. doi: 10.1001/jama.2023.25077.
    PubMed    
    
    
    November 2023
16. CHEN TL, Chuang HK, Wu CY
    Violaceous Nodules on the Right Leg and Foot.
    JAMA. 2023 Nov 20. doi: 10.1001/jama.2023.20118.
    PubMed    
    
    
    October 2023
17. HARRIS E
    Trial Launches of New HIV Vaccine Candidate With CMV Vector.
    JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19203.
    PubMed    
    
    
    September 2023
18. GANDHI M, Goosby E
    PEPFAR Reauthorization by Congress Urgent for Global Health.
    JAMA. 2023 Sep 14. doi: 10.1001/jama.2023.19322.
    PubMed    
    
    
    
19. HARRIS E
    Many Medicaid Enrollees Do Not Receive Needed HIV Care.
    JAMA. 2023 Sep 13. doi: 10.1001/jama.2023.17174.
    PubMed    
    
    
    August 2023
20. LIU AY, Scott HM, Buchbinder SP
    New USPSTF Guidelines for HIV Preexposure Prophylaxis: Will More Choices Lead to Greater Impact?
    JAMA. 2023;330:699-701.
    PubMed    
    
    
    
21. 
    Preventing HIV With PrEP.
    JAMA. 2023;330:777-778.
    PubMed    
    
    
    
22. CHOU R, Spencer H, Bougatsos C, Blazina I, et al
    Preexposure Prophylaxis for the Prevention of HIV: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2023;330:746-763.
    PubMed     Abstract available
    
    
    
23. BARRY MJ, Nicholson WK, Silverstein M, Chelmow D, et al
    Preexposure Prophylaxis to Prevent Acquisition of HIV: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2023;330:736-745.
    PubMed     Abstract available
    
    
    June 2023
24. NKENGASONG J, Zaidi I, Katz IT
    PEPFAR at 20-Looking Back and Looking Ahead.
    JAMA. 2023 Jun 9. doi: 10.1001/jama.2023.9291.
    PubMed    
    
    
    
25. HARRIS E
    Decline in New HIV Cases Projected to Fall Short of US Goals.
    JAMA. 2023 Jun 7. doi: 10.1001/jama.2023.9924.
    PubMed    
    
    
    May 2023
26. HARRIS E
    HIV Status Not Linked to Treatment Outcomes for People With Mpox.
    JAMA. 2023 May 3. doi: 10.1001/jama.2023.7767.
    PubMed    
    
    
    
27. HARRIS E
    Urine Tests May Miss More Than 400 000 STIs in the US Every Year.
    JAMA. 2023;329:1443.
    PubMed    
    
    
    April 2023
28. HARRIS E
    Daily Statin Trial for People With HIV Halted Early for Clear Benefit.
    JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6619.
    PubMed    
    
    
    
29. HARRIS E
    STI Epidemic Worsened in 2021, Syphilis Cases Surged.
    JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6620.
    PubMed    
    
    
    
30. HARRIS E
    World on Path to Eliminate AIDS as a Global Threat by 2030.
    JAMA. 2023;329:1248.
    PubMed    
    
    
    
31. GLUCK AR, Gostin LO
    Cost-Free Preventive Care Under the ACA Faces Legal Challenge.
    JAMA. 2023 Apr 10. doi: 10.1001/jama.2023.6584.
    PubMed    
    
    
    
32. BAROCAS JA, Nall SK, Axelrath S, Pladsen C, et al
    Population-Level Health Effects of Involuntary Displacement of People Experiencing Unsheltered Homelessness Who Inject Drugs in US Cities.
    JAMA. 2023 Apr 10. doi: 10.1001/jama.2023.4800.
    PubMed     Abstract available
    
    
    
33. EKE AC, Lockman S, Mofenson LM
    Antiretroviral Treatment of HIV/AIDS During Pregnancy.
    JAMA. 2023 Apr 3. doi: 10.1001/jama.2023.5076.
    PubMed    
    
    
    March 2023
34. HARRIS E
    First HIV Remission in Patient Treated With Stem Cells From Cord Blood.
    JAMA. 2023 Mar 22. doi: 10.1001/jama.2023.4008.
    PubMed    
    
    
    
35. HARRIS E
    Severe Form of Mpox Identified in Patients With Advanced HIV.
    JAMA. 2023 Mar 8. doi: 10.1001/jama.2023.3191.
    PubMed    
    
    
    
36. RUBIN R
    Highlights From CROI, the Conference on Retroviruses and Opportunistic Infections-Postexposure Prophylaxis for Sexually Transmitted Infections, a New Protease Inhibitor for COVID-19, Goals for Preventing HIV Transmission, and More.
    JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.0158.
    PubMed    
    
    
    February 2023
37. SURAN M
    New HIV Vaccine Approach Safely Stimulated Rare Precursors to Broadly Neutralizing Antibodies.
    JAMA. 2023 Feb 1. doi: 10.1001/jama.2022.23242.
    PubMed    
    
    
    January 2023
38. ZALLA LC, Cole SR, Eron JJ, Adimora AA, et al
    Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US.
    JAMA. 2023;329:52-62.
    PubMed     Abstract available
    
    
    December 2022
39. KELS CG
    Consent Laws for Minors Regarding Sexually Transmitted Infection and HIV Services.
    JAMA. 2022;328:2363-2364.
    PubMed    
    
    
    
40. UNDERHILL K, Nelson KM
    Consent Laws for Minors Regarding Sexually Transmitted Infection and HIV Services-Reply.
    JAMA. 2022;328:2364.
    PubMed    
    
    
    
41. KUEHN BM
    Early Treatment Recommended for Patients With HIV and Monkeypox.
    JAMA. 2022;328:2203.
    PubMed    
    
    
    
42. HADDAD M, Person AK, Tookes HE
    Ending the HIV Epidemic: We Have the Tools, Do We Have the Will?
    JAMA. 2022 Dec 1. doi: 10.1001/jama.2022.22569.
    PubMed    
    
    
    
43. GANDHI RT, Bedimo R, Hoy JF, Landovitz RJ, et al
    Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.
    JAMA. 2022 Dec 1. doi: 10.1001/jama.2022.22246.
    PubMed     Abstract available
    
    
    November 2022
44. SURAN M
    Highlights From Infectious Disease Week 2022-COVID-19, HIV, Monkeypox, and Polio.
    JAMA. 2022 Nov 9. pii: 2798547. doi: 10.1001/jama.2022.17754.
    PubMed    
    
    
    October 2022
45. JOHNSTON C, Magaret A, Son H, Stern M, et al
    Viral Shedding 1 Year Following First-Episode Genital HSV-1 Infection.
    JAMA. 2022 Oct 22. pii: 2797619. doi: 10.1001/jama.2022.19061.
    PubMed     Abstract available
    
    
    
46. BELLANDI D
    An Association Between Heavy Rainfall and HIV in Sub-Saharan Africa.
    JAMA. 2022;328:1490.
    PubMed    
    
    
    
47. WULF HANSON S, Abbafati C, Aerts JG, Al-Aly Z, et al
    Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
    JAMA. 2022 Oct 10. pii: 2797443. doi: 10.1001/jama.2022.18931.
    PubMed     Abstract available
    
    
    September 2022
48. KUEHN BM
    Interim Guidance for Monkeypox Among Patients With HIV.
    JAMA. 2022;328:1173-1174.
    PubMed    
    
    
    
49. FEINSTEIN MJ
    HIV, Subclinical Cardiovascular Disease, and Clinical Progression: Insights From Immunologic Heterogeneity.
    JAMA. 2022;328:931-932.
    PubMed    
    
    
    
50. HUDSON JA, Majonga ED, Ferrand RA, Perel P, et al
    Association of HIV Infection With Cardiovascular Pathology Based on Advanced Cardiovascular Imaging: A Systematic Review.
    JAMA. 2022;328:951-962.
    PubMed     Abstract available
    
    
    August 2022
51. NELSON KM, Skinner A, Underhill K
    Minor Consent Laws for Sexually Transmitted Infection and HIV Services.
    JAMA. 2022;328:674-676.
    PubMed    
    
    
    
52. KUEHN BM
    Reduced HIV Testing and Diagnoses During COVID-19 Pandemic.
    JAMA. 2022;328:519.
    PubMed    
    
    
    July 2022
53. LARKIN HD
    Dual Anti-HIV Antibodies Provide Long-term Viral Suppression.
    JAMA. 2022;328:122.
    PubMed    
    
    
    May 2022
54. MCCLYMONT E, Albert AY, Alton GD, Boucoiran I, et al
    Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal Outcomes.
    JAMA. 2022 May 2. pii: 2792031. doi: 10.1001/jama.2022.5906.
    PubMed     Abstract available
    
    
    April 2022
55. RUOPP NF, Cockrill BA
    Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.
    JAMA. 2022;327:1379-1391.
    PubMed     Abstract available
    
    
    
56. LARKIN HD
    First Condom Authorized Specifically for Anal Intercourse.
    JAMA. 2022;327:1219.
    PubMed    
    
    
    March 2022
57. MAYER KH, Allan-Blitz LT
    Enhancing HIV Prevention With New Modalities and Routine Sexual History Discussions.
    JAMA. 2022 Mar 28. pii: 2790710. doi: 10.1001/jama.2022.3848.
    PubMed    
    
    
    
58. COREY L, Corbett-Detig R, Beyrer C
    Expanding Efforts and Support to Respond to the HIV and COVID-19 Intersecting Pandemics.
    JAMA. 2022 Mar 11. pii: 2790239. doi: 10.1001/jama.2022.3517.
    PubMed    
    
    
    
59. ABBASI J
    First mRNA HIV Vaccine Clinical Trial Launches.
    JAMA. 2022;327:909.
    PubMed    
    
    
    February 2022
60. PATEL EU, Genberg BL, Zhu X, Krawczyk N, et al
    HIV and Hepatitis C Virus Testing and Treatment Services in Specialty Treatment Facilities That Offer Medication for Opioid Use Disorder in the US.
    JAMA. 2022;327:776-777.
    PubMed    
    
    
    
61. SHARFSTEIN JM, Killelea A, Dangerfield D
    Long-Acting Cabotegravir for HIV Prevention: Issues of Access, Cost, and Equity.
    JAMA. 2022 Feb 14. pii: 2789293. doi: 10.1001/jama.2022.0420.
    PubMed    
    
    
    January 2022
62. CHRISTENSEN BW, Li HC, Huerta S
    Blurred Vision and Gastrointestinal Bleeding in a Patient With HIV.
    JAMA. 2022;327:276-277.
    PubMed    
    
    
    
63. MAFI JN, Craff M, Vangala S, Pu T, et al
    Trends in US Ambulatory Care Patterns During the COVID-19 Pandemic, 2019-2021.
    JAMA. 2022;327:237-247.
    PubMed     Abstract available
    
    
    
64. KUEHN BM
    Global HIV Suppression Rates Fall Short of Targets.
    JAMA. 2022;327:209.
    PubMed    
    
    
    
65. TUDDENHAM S, Hamill MM, Ghanem KG
    Diagnosis and Treatment of Sexually Transmitted Infections: A Review.
    JAMA. 2022;327:161-172.
    PubMed     Abstract available
    
    
    December 2021
66. RUBIN R
    Questions Remain About Who Will Get Monoclonal Antibodies for COVID-19 Preexposure Prophylaxis.
    JAMA. 2021 Dec 29. pii: 2787758. doi: 10.1001/jama.2021.23557.
    PubMed    
    
    
    November 2021
67. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
    JAMA. 2021 Nov 1. pii: 2785918. doi: 10.1001/jama.2021.19623.
    PubMed     Abstract available
    
    
    October 2021
68. KUEHN BM
    COVID-19 Rolls Back Progress Against HIV, TB, and Malaria.
    JAMA. 2021;326:1471.
    PubMed    
    
    
    September 2021
69. ZUGER A
    Preventing a Pandemic's Toll-We've Been Here Before.
    JAMA. 2021;326:909-910.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.